AIM IMMUNOTECH INC. Net Income
AIM IMMUNOTECH INC. (AIM) reported Net Income of -$3.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-07
- AIM IMMUNOTECH INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$3.79M.
- AIM IMMUNOTECH INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$3.02M.
- AIM IMMUNOTECH INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$4.17M.
- AIM IMMUNOTECH INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$3.28M.
- AIM IMMUNOTECH INC. net income (loss) attributable to parent for fiscal 2025 was -$13.96M.
- AIM IMMUNOTECH INC. net income (loss) attributable to parent for fiscal 2024 was -$17.32M.
- AIM IMMUNOTECH INC. net income (loss) attributable to parent for fiscal 2023 was -$28.96M.
- AIM IMMUNOTECH INC. net income (loss) attributable to parent for fiscal 2022 was -$19.45M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.79M 10-Q · filed 2026-08-07 | -$6.81M 10-Q · filed 2026-08-07 | -$10.99M derived: sum of 3 quarters · filed 2026-08-07 | -$14.27M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$3.02M 10-Q · filed 2026-08-07 | -$7.20M derived: sum of 2 quarters · filed 2026-08-07 | -$10.48M derived: sum of 3 quarters · filed 2026-08-07 | -$13.28M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$7.46M derived: sum of 2 quarters · filed 2026-03-27 | -$10.25M derived: sum of 3 quarters · filed 2026-08-07 | -$13.96M 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | -$3.28M 10-Q · filed 2025-11-17 | -$6.08M derived: sum of 2 quarters · filed 2026-08-07 | -$9.78M 10-Q · filed 2025-11-17 | -$15.75M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$2.79M 10-Q · filed 2026-08-07 | -$6.50M 10-Q · filed 2026-08-07 | -$12.47M derived: sum of 3 quarters · filed 2026-08-07 | -$16.17M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$3.71M 10-Q · filed 2026-08-07 | -$9.67M derived: sum of 2 quarters · filed 2026-08-07 | -$13.37M derived: sum of 3 quarters · filed 2026-08-07 | -$15.21M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2024-12-31 | -$5.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$9.67M derived: sum of 2 quarters · filed 2026-03-27 | -$11.50M derived: sum of 3 quarters · filed 2026-03-27 | -$17.32M 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | -$3.70M 10-Q · filed 2025-11-17 | -$5.54M derived: sum of 2 quarters · filed 2025-11-17 | -$11.35M 10-Q · filed 2025-11-17 | -$23.93M derived: sum of 4 quarters · filed 2025-11-17 | ||||
| 2024-06-30 | -$1.84M 10-Q · filed 2025-11-17 | -$7.65M 10-Q · filed 2025-08-14 | -$20.23M derived: sum of 3 quarters · filed 2025-11-17 | -$28.05M derived: sum of 4 quarters · filed 2025-11-17 | ||||
| 2024-03-31 | -$5.82M 10-Q · filed 2025-11-17 | -$18.39M derived: sum of 2 quarters · filed 2025-11-17 | -$26.21M derived: sum of 3 quarters · filed 2025-11-17 | -$31.12M derived: sum of 4 quarters · filed 2025-11-17 | ||||
| 2023-12-31 | -$12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$20.39M derived: sum of 2 quarters · filed 2025-03-27 | -$25.30M derived: sum of 3 quarters · filed 2025-03-27 | -$28.96M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$7.82M 10-Q · filed 2024-11-14 | -$12.72M derived: sum of 2 quarters · filed 2024-11-14 | -$16.39M 10-Q · filed 2024-11-14 | -$20.77M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$4.91M 10-Q · filed 2024-08-14 | -$8.57M 10-Q · filed 2024-08-14 | -$12.96M derived: sum of 3 quarters · filed 2024-08-14 | -$19.34M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$3.66M 10-Q · filed 2024-05-15 | -$8.05M derived: sum of 2 quarters · filed 2024-05-15 | -$14.44M derived: sum of 3 quarters · filed 2024-05-15 | -$19.29M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$10.77M derived: sum of 2 quarters · filed 2024-04-01 | -$15.63M derived: sum of 3 quarters · filed 2024-04-01 | -$19.45M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$6.38M 10-Q · filed 2023-11-14 | -$11.24M derived: sum of 2 quarters · filed 2023-11-14 | -$15.06M 10-Q · filed 2023-11-14 | -$20.90M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$4.85M 10-Q · filed 2023-08-14 | -$8.67M 10-Q · filed 2023-08-14 | -$14.52M derived: sum of 3 quarters · filed 2023-08-14 | -$18.34M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$3.82M 10-Q · filed 2023-05-15 | -$9.67M derived: sum of 2 quarters · filed 2023-05-15 | -$13.49M derived: sum of 3 quarters · filed 2023-05-15 | -$19.37M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$9.67M derived: sum of 2 quarters · filed 2023-03-31 | -$15.55M derived: sum of 3 quarters · filed 2023-03-31 | -$19.13M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$3.83M 10-Q · filed 2022-11-14 | -$9.70M derived: sum of 2 quarters · filed 2022-11-14 | -$13.28M 10-Q · filed 2022-11-14 | -$17.21M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$5.88M 10-Q · filed 2022-08-15 | -$9.46M 10-Q · filed 2022-08-15 | -$13.39M derived: sum of 3 quarters · filed 2022-08-15 | -$16.70M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$3.58M 10-Q · filed 2022-05-13 | -$7.51M derived: sum of 2 quarters · filed 2022-05-13 | -$10.82M derived: sum of 3 quarters · filed 2022-05-13 | -$14.19M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$7.24M derived: sum of 2 quarters · filed 2022-03-31 | -$10.61M derived: sum of 3 quarters · filed 2022-03-31 | -$14.40M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$3.31M 10-Q · filed 2021-11-15 | -$6.68M derived: sum of 2 quarters · filed 2021-11-15 | -$10.47M 10-Q · filed 2021-11-15 | -$11.55M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$3.37M 10-Q · filed 2021-08-16 | -$7.16M 10-Q · filed 2021-08-16 | -$8.24M derived: sum of 3 quarters · filed 2021-08-16 | -$11.19M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$3.81M 10-Q · filed 2021-05-17 | -$4.87M derived: sum of 2 quarters · filed 2021-05-17 | -$7.82M derived: sum of 3 quarters · filed 2021-05-17 | -$9.86M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$4.01M derived: sum of 2 quarters · filed 2021-03-31 | -$6.05M derived: sum of 3 quarters · filed 2021-03-31 | -$9.40M 10-K · filed 2021-03-31 | -$9.53M 10-K · filed 2020-03-30 | |||
| 2019-09-30 | -$2.95M 10-Q · filed 2020-11-12 | -$4.98M derived: sum of 2 quarters · filed 2020-11-12 | -$8.34M 10-Q · filed 2020-11-12 | -$8.35M 10-Q · filed 2019-11-14 | -$9.97M derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | -$2.04M 10-Q · filed 2020-08-14 | -$2.03M 10-Q · filed 2019-08-14 | -$5.39M 10-Q · filed 2020-08-14 | -$5.40M 10-Q · filed 2019-08-14 | -$7.02M derived: sum of 3 quarters · filed 2020-08-14 | -$10.10M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | -$3.37M 10-Q · filed 2020-05-14 | -$3.37M 10-Q · filed 2019-05-15 | -$4.99M derived: sum of 2 quarters · filed 2020-05-14 | -$8.06M derived: sum of 3 quarters · filed 2020-05-14 | -$10.48M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$4.70M derived: sum of 2 quarters · filed 2020-03-30 | -$7.11M derived: sum of 3 quarters · filed 2020-03-30 | -$9.83M 10-K · filed 2020-03-30 | -$9.81M 10-K · filed 2019-04-01 | |||
| 2018-09-30 | -$3.08M 10-Q · filed 2019-11-14 | -$5.49M derived: sum of 2 quarters · filed 2019-11-14 | -$8.21M 10-Q · filed 2019-11-14 | -$10.20M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$2.42M 10-Q · filed 2019-08-14 | -$5.13M 10-Q · filed 2019-08-14 | -$7.12M derived: sum of 3 quarters · filed 2019-08-14 | -$8.37M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$2.71M 10-Q · filed 2019-05-15 | -$4.71M derived: sum of 2 quarters · filed 2019-05-15 | -$5.96M derived: sum of 3 quarters · filed 2019-05-15 | -$8.15M derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$3.25M derived: sum of 2 quarters · filed 2019-04-01 | -$5.44M derived: sum of 3 quarters · filed 2019-04-01 | -$8.26M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | -$1.25M 10-Q · filed 2018-11-14 | -$3.44M derived: sum of 2 quarters · filed 2018-11-14 | -$6.27M 10-Q · filed 2018-11-14 | -$7.44M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | -$2.19M 10-Q · filed 2018-08-14 | -$5.01M 10-Q · filed 2018-08-14 | -$6.19M derived: sum of 3 quarters · filed 2018-08-14 | -$9.05M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | -$2.82M 10-Q · filed 2018-05-15 | -$3.99M derived: sum of 2 quarters · filed 2018-05-15 | -$6.86M derived: sum of 3 quarters · filed 2018-05-15 | -$8.16M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$4.04M derived: sum of 2 quarters · filed 2018-03-30 | -$5.34M derived: sum of 3 quarters · filed 2018-03-30 | -$7.50M 10-K · filed 2018-03-30 | ||||
| 2016-09-30 | -$2.86M 10-Q · filed 2017-11-14 | -$4.17M derived: sum of 2 quarters · filed 2017-11-14 | -$6.33M 10-Q · filed 2017-11-14 | -$9.47M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2016-06-30 | -$1.30M 10-Q · filed 2017-08-14 | -$3.47M 10-Q · filed 2017-08-14 | -$6.60M derived: sum of 3 quarters · filed 2018-03-30 | -$10.41M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2016-03-31 | -$2.16M 10-Q · filed 2017-05-15 | -$5.30M derived: sum of 2 quarters · filed 2018-03-30 | -$9.10M derived: sum of 3 quarters · filed 2018-03-30 | -$13.95M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2015-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$6.94M derived: sum of 2 quarters · filed 2018-03-30 | -$11.79M derived: sum of 3 quarters · filed 2018-03-30 | -$15.23M 10-K · filed 2018-03-30 | ||||
| 2015-09-30 | -$3.80M 10-Q · filed 2016-11-14 | -$8.65M derived: sum of 2 quarters · filed 2016-11-14 | -$12.09M 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | -$4.84M 10-Q · filed 2016-08-15 | -$8.29M 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | -$3.44M 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | -$17.45M 10-K · filed 2017-03-31 | |||||||
| 2013-12-31 | -$16.23M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |